Skip to main content
Search

# BiGSyn

1 related articles

Subscribe to updates
  1. arXiv

    Drug synergy prediction stops choosing between molecules and networks: BiGSyn aligns both graph levels and reaches 94.37 AUC on the independent test

    Drug synergy prediction has mostly been modeled at a single level, using either atom-level molecular graphs or a biological network of drugs, targets, cell lines and tissues, so cross-level signals were hard to fuse. BiGSyn uses heterogeneous graph transformers to learn representations from molecular graphs and biological subgraphs, then a bi-level contrastive objective pulls the two representations of the same drug together. On the Oncology-Screen and DrugCombDB benchmarks it beats six compared methods on independent-test metrics, with an AUC of 94.37 on Oncology-Screen.

You’re all caught up